Patients’ needs in proton therapy: A survey among ten European facilities

Clinical and Translational Radiation Oncology - Tập 43 - Trang 100670 - 2023
G.C. Mazzola1,2, L. Bergamaschi1,2, C. Pedone1,2, M.G. Vincini1, M. Pepa1, M. Zaffaroni1, S. Volpe1,2, B. Rombi3, J. Doyen4, P. Fossati5, K. Haustermans6, M. Høyer7, J.A. Langendijk8, R. Matute9, E. Orlandi10, H. Rylander11, E.G.C. Troost12,13,14, R. Orecchia1, D. Alterio1, B.A. Jereczek-Fossa1,2
1Division of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milan, Italy
2Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy
3Proton Therapy Center, Trento, Italy
4Centre Antoine-Lacassagne, Nice, France
5MedAustron Ion Therapy Center, Wiener Neustadt, Austria
6PARTICLE Proton Therapy Center, Leuven, Belgium
7Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark
8University Medical Center Groningen, Groningen, The Netherlands
9Centro de Protonterapia Quironsalud, Madrid, Spain
10CNAO National Center for Oncological Hadrontherapy, Pavia, Italy
11The Skandion Clinic, Uppsala, Sweden
12Faculty of Medicine and University Hospital Carl Gustav Carus, Department of Radiotherapy and Radiation Oncology, Dresden, Germany
13OncoRay - National Center for Radiation Research in Oncology: Faculty of Medicine and University Hospital Carl Gustav Carus, Dresden; Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany
14Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany

Tài liệu tham khảo

Amini, 2017, Patient Characterization and Usage Trends of Proton Beam Therapy for Localized Prostate Cancer in the United States: A Study of the National Cancer Database, Urol Oncol, 35, 438, 10.1016/j.urolonc.2017.01.013 Bortfeld, 2021, The Societal Impact of Ion Beam Therapy, Zeitschrift für Medizinische Physik, 31, 102, 10.1016/j.zemedi.2020.06.007 ESTRO. 2018. The White Paper in Radiotherapy: seizing the opportunity in cancer care. Grau, 2020, Particle Therapy in Europe, Mol Oncol, 14, 1492, 10.1002/1878-0261.12677 Jarosek, Stephanie, Sean Elliott, Beth A. Virnig. 2011. Proton Beam Radiotherapy in the U.S. Medicare Population: Growth in Use between 2006 and 2009: Data Points # 10. in Data Points Publication Series. Rockville (MD): Agency for Healthcare Research and Quality (US). Kim, 2018, Proton Therapy for Head and Neck Cancer, Curr Treat Options Oncol, 19, 28, 10.1007/s11864-018-0546-9 Kubeš, 2021, Ultrahypofractionated Proton Radiation Therapy in the Treatment of Low and Intermediate-Risk Prostate Cancer-5-Year Outcomes, Int J Radiat Oncol Biol Phys, 110, 1090, 10.1016/j.ijrobp.2021.02.014 Lee, 2019, Trends and Disparities of Proton Therapy Use among Patients with Head and Neck Cancer: Analysis from the National Cancer Database (2005–14), Int J Particle Ther, 5, 1, 10.14338/IJPT-19-00051.1 Mahal, 2016, National Trends and Determinants of Proton Therapy Use for Prostate Cancer: A National Cancer Data Base Study, Cancer, 122, 1505, 10.1002/cncr.29960 Maillie, 2021, Geospatial Disparities in Access to Proton Therapy in the Continental United States, Cancer Invest, 39, 582, 10.1080/07357907.2021.1944180 Mohan, 2022, A Review of Proton Therapy - Current Status and Future Directions, Precision Radiat Oncol, 6, 164, 10.1002/pro6.1149 Nogueira, 2022, Assessment of Proton Beam Therapy Use Among Patients With Newly Diagnosed Cancer in the US, 2004–2018, JAMA Netw Open, 5, e229025, 10.1001/jamanetworkopen.2022.9025 Nogueira, 2022, Association of Race With Receipt of Proton Beam Therapy for Patients With Newly Diagnosed Cancer in the US, 2004–2018, JAMA Netw Open, 5, e228970, 10.1001/jamanetworkopen.2022.8970 Ohlsson-Nevo, 2020, Patients’ Perspective in the Context of Proton Beam Therapy: Summary of a Nordic Workshop, Acta Oncologica (Stockholm, Sweden), 59, 1139, 10.1080/0284186X.2020.1762927 Shen, 2017, Socioeconomic Factors Affect the Selection of Proton Radiation Therapy for Children, Cancer, 123, 4048, 10.1002/cncr.30849 Tambas, 2022, Current Practice in Proton Therapy Delivery in Adult Cancer Patients across Europe, Radiother Oncol: J Eur Soc Ther Radiol Oncol, 167, 7, 10.1016/j.radonc.2021.12.004 Thijssen, 2023, Clues to Address Barriers for Access to Proton Therapy in the Netherlands, Radiother Oncol: J Eur Soc Ther Radiol Oncol, 178, 10.1016/j.radonc.2022.11.021 Xia, 2022, Inequality in Accessibility of Proton Therapy for Cancers and Its Economic Determinants: A Cross-Sectional Study, Front Oncol, 12 Yu, 2013, Proton versus Intensity-Modulated Radiotherapy for Prostate Cancer: Patterns of Care and Early Toxicity, J Natl Cancer Inst, 105, 25, 10.1093/jnci/djs463 Zientara, 2022, A Scoping Review of Patient Selection Methods for Proton Therapy, J Med Radiat Sci, 69, 108, 10.1002/jmrs.540 Volpe, 2022, Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis, Cancer Treat Rev., 110, 10.1016/j.ctrv.2022.102464